Admission Date:  [**2164-9-27**]              Discharge Date:   [**2164-10-11**]  Date of Birth:  [**2096-6-9**]             Sex:   F  Service: MEDICINE  Allergies: Latex / Oxaliplatin / Iodine; Iodine Containing / Fluconazole / Ace Inhibitors  Attending:[**First Name3 (LF) 5141**] Chief Complaint: Hypotension, GI bleed  Major Surgical or Invasive Procedure: Central Line placement and removal (internal jugular line) PICC line placement  History of Present Illness: Ms. [**Known lastname 69629**] is a 68-year-old woman with a history of stage IV metastatic colon cancer complicated by an enterocutaneous fistula and extensive spread of carcinoma into the osotomy bag who presents with acute on chronic bleeding into her ostomy.
Patient had been on ASA and lovenox as outpatient, was given protamine and 4U pRBCs.
She was discharged off aspirin and lovenox due to the risk of bleeding.
She has been taking vancomycin and ceftriaxone at rehab (day [**8-25**]; vanco was to be held today due to high trough).
On arrival to the ED, she triggered for hypotension initially, but was mentating well and asymptomatic.
She received 4 L of crystaloid, 1 unit of uncrossed PRBC and was started on levofed for her hypotension.
Due to concern re: sepsis physiology, she also received vancomycin and zosyn.
For IV access, she has a right-sided PICC, which flushed but dose not draw per ED, and a left IJ was placed in ED.
She has been getting heparin SC TID at rehab.
Denies chest pain, chest pressure, palpitations, lightheadeness/dizziness or weakness.
Past Medical History: - Metastatic colon ca (known mets to lungs) - Right colectomy with ileo-colic anastamosis - Depression - Pulmonary Embolism  - lovenox d/c'ed in past r/t high risk of recurrent bleeding.
She is status post multiple systemic chemotherapies, most recent regimen included 33 cycles of infusional 5-FU and leucovorin, and most recently she has been started on single [**Doctor Last Name 360**] panitumumab, she received her first dose on [**2164-6-1**].
She has also had a reaction to oxaliplatin in the past.
She is not currently a candidate for chemotherapy per recent d/c summary.
Family History: father w/ prostate ca; grandma w/ liver ca  Physical Exam: Vitals: T 98.6, HR 111, BP 109/64, RR17, SpO2 98% 3L NC General: Sleepy but easily arousable, oriented x3, no acute distress HEENT: NCAT, PERRL, EOMI, Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD, LIJ in place.
no wheezes, ronchi CV: rapid rate, regular rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: left colostomy in place with fungating mass protruding, no red blood in bag and modertate amount of brown fecal material in ostomy, normal active bowel sounds, abdomen soft, non-tender, non-distended, no rebound tenderness or guarding.
New left internal jugular approach venous catheter with tip in mid SVC.
The left kidney measures 9.8 cm.
The right cephalic vein, axillary vein, subclavian and right internal jugular vein are all patent and demonstrates normal flow and compressibility.
Seen by surgery who recommended surgicel and said no role for surgical intervention.
25mg IV Protamine given one time.
Pt did not respond to PO Vitamin K so one dose of IV vit K given and INR came down.
She was most recently being treated with Vanco/Ceftriaxone at her [**Hospital1 1501**] for pan-sensitive Entercoccal & E. Coli bacteremia (still getting course of therapy when admitted).
Vanco trough was high at [**Hospital1 1501**] before admit but patient was given a dose of Vancomycin in the ED.
Antibiotics were switched to Vanco/Cefepime with Vanco held for high trough (was 50.6 on [**9-28**] AM draw).
Patient was still orthostatic after fluid so albumin infusion was given along with 2 units PRBC as noted above and urine output picked up.
Briefly, patient was given stress dose steroids for random cortisol of 12.4.
ID stated that antibiotics course could be stopped after doses given on [**10-2**], however, patient had evidence of UTI at that time, and cefepime was continued.
PICC line was left in place from previous admission, which was the patient's only source of access.
There was concern for infectious etiology, for which patient was at the time being treated with cefepime for UTI.
Goals of care discussion was had with patient, and she revealed that she would like to be DNR/DNI, with focus on comfort measures.
Area around PICC insertion was slightly erythematous, but since this was the patient's only IV access, the line was not pulled.
# Metastatic Colon Cancer: Pt not felt to be candidate for further chemotherapy.
Pain was controled with fentanyl, morphine IR & MS contin.
Goals of care discussions were had at that time, and patient revealed that she would prefer to be DNR/DNI, with focus on comfort measures.
Vancomycin was held while in ICU and troughs were followed but never became sub-threrapeutic before floor transfer.
Vancomycin was discontinued after transfer from ICU per ID recommendations, with remaining supratherapeutic levels.
Patient was given fluids after leaving the ICU, for which her kidney function slowly recovered.
Pt was given IV lasix on [**9-30**] as mentioned above.
She did not require further diuretic administration.
Medications on Admission: Morphine SR (MS Contin) 100 mg PO Q12H Ondansetron 8 mg IV Q8H:PRN nausea Acetaminophen 325-650 mg PO/NG Q6H:PRN fever/pain Opium Tincture 15 DROP PO/NG Q 12H CefePIME 1 g IV Q24H Pantoprazole 40 mg IV Q24H Ferrous Gluconate 325 mg PO TID Prochlorperazine 10 mg PO Q6H:PRN nausea Lorazepam 0.5 mg PO/NG TID Psyllium Wafer 1 WAF PO TID Megestrol Acetate 40 mg PO QID Rifaximin 200 mg PO/NG TID MetRONIDAZOLE (FLagyl) 500 mg PO/NG Q8H Miconazole 2% Cream 1 Appl TP [**Hospital1 **] Duration: 14 Days Apply to rash on back.
Sodium Bicarbonate 650 mg PO/NG TID Mirtazapine 15 mg PO/NG HS Miconazole Powder 2% 1 Appl TP [**Hospital1 **]:PRN apply to folds and groin as needed Morphine Sulfate 4-6 mg IV Q4H:PRN pain   Discharge Medications: 1.
Mirtazapine 15 mg Tablet [**Hospital1 **]: One (1) Tablet PO HS (at bedtime).
Morphine 100 mg Tablet Sustained Release [**Hospital1 **]: One (1) Tablet Sustained Release PO Q12H (every 12 hours).
Acetaminophen 325 mg Tablet [**Hospital1 **]: 1-2 Tablets PO every six (6) hours as needed for fever or pain.
Pantroprazole 40 mg IV  [**Hospital1 **]: One (1)   once a day.
Ferrous Sulfate 325 mg (65 mg Iron) Tablet [**Hospital1 **]: One (1) Tablet PO three times a day.
Prochlorperazine Maleate 10 mg Tablet [**Hospital1 **]: One (1) Tablet PO every six (6) hours as needed for nausea.
Lorazepam 0.5 mg Tablet [**Hospital1 **]: One (1) Tablet PO three times a day.
Morphine sulfate 4-6 mg IV  [**Hospital1 **]: One (1)   every four (4) hours as needed for pain.
Miconazole Nitrate 2 % Powder [**Hospital1 **]: One (1) application Topical twice a day.
You received fluids and some blood products and improved.
During this admission you also completed your course of antibiotics from a gastrointestinal infection from a prior hospitalization.
The following changes were made to your medications: -- STOP Cefepime 1 g intravenously every 24 hours: you completed the course of this antibiotic this hospitalization -- STOP Flagyl 500 mg by mouth every eight hours: you completed the course of this antibiotic this admission -- STOP Miconazole 2% Cream, one application to the skin: you completed your 14-day course during this hospitalization  Followup Instructions: No follow-up    Completed by:[**2164-10-14**
